Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan.
Igarashi, Ataru; Maruyama-Sakurai, Keiko; Kubota, Anna; Akiyama, Hiroki; Yajima, Toshitaka; Kohsaka, Shun; Miyata, Hiroaki.
Afiliação
  • Igarashi A; Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Japan. atarui1@mac.com.
  • Maruyama-Sakurai K; Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. atarui1@mac.com.
  • Kubota A; Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan. atarui1@mac.com.
  • Akiyama H; Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan.
  • Yajima T; Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan.
  • Kohsaka S; Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K., Osaka, Japan.
  • Miyata H; Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K., Osaka, Japan.
Diabetes Ther ; 13(7): 1367-1381, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35710646
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article